Literature DB >> 16123759

NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice.

Hiroki Ishiguro1, Qing-Rong Liu, Jian-Ping Gong, Frank Scott Hall, Hiroshi Ujike, Marisela Morales, Takeshi Sakurai, Martin Grumet, George R Uhl.   

Abstract

Several lines of evidence support roles for the cell adhesion molecule NrCAM in addictions. Fine mapping within a chromosome 7 region that contains previously linked and associated genomic markers identifies NrCAM haplotypes that are associated with substance abuse vulnerabilities in four samples of abusers and controls. Differential display identifies NrCAM as a drug regulated gene. NrCAM is expressed in neurons linked to reward and memory. NrCAM displays haplotype-specific gene expression in human post-mortem brain samples. Knockout mice display reduced opiate- and stimulant-conditioned place preferences. These observations support NrCAM as a positionally cloned and drug-regulated gene whose variants are likely to change expression and alter substance abuse vulnerabilities in human addictions and animal models of drug reward.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16123759     DOI: 10.1038/sj.npp.1300855

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  38 in total

Review 1.  Molecular genetics of addiction vulnerability.

Authors:  George R Uhl
Journal:  NeuroRx       Date:  2006-07

Review 2.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

3.  Cell adhesion molecules: druggable targets for modulating the connectome and brain disorders?

Authors:  George R Uhl; Jana Drgonova
Journal:  Neuropsychopharmacology       Date:  2014-01       Impact factor: 7.853

4.  NrCAM deletion causes topographic mistargeting of thalamocortical axons to the visual cortex and disrupts visual acuity.

Authors:  Galina P Demyanenko; Thorfinn T Riday; Tracy S Tran; Jasbir Dalal; Eli P Darnell; Leann H Brennaman; Takeshi Sakurai; Martin Grumet; Benjamin D Philpot; Patricia F Maness
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

Review 5.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

6.  Single cell adhesion measuring apparatus (SCAMA): application to cancer cell lines of different metastatic potential and voltage-gated Na+ channel expression.

Authors:  Christopher P Palmer; Maria E Mycielska; Hakan Burcu; Kareem Osman; Timothy Collins; Rachel Beckerman; Rebecca Perrett; Helen Johnson; Ebru Aydar; Mustafa B A Djamgoz
Journal:  Eur Biophys J       Date:  2007-09-19       Impact factor: 1.733

Review 7.  The Opioid-Addicted Tetrapartite Synapse.

Authors:  Anna Kruyer; Vivian C Chioma; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2019-06-13       Impact factor: 13.382

Review 8.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 9.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

10.  Xenopus laevis neuronal cell adhesion molecule (nrcam): plasticity of a CAM in the developing nervous system.

Authors:  Ashwin Lokapally; Sanjeeva Metikala; Thomas Hollemann
Journal:  Dev Genes Evol       Date:  2016-12-10       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.